Nachrichten zur Trinity Biotech ADR Aktie

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

DUBLIN, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on…

Trinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service

FDA-cleared PreClara™ Ratio (sFlt-1/PlGF) biomarker test offers clinicians a crucial tool for managing hypertensive disorders of pregnancy, with potential significant…

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement

DUBLIN, March 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on…

Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan

DUBLIN, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on…

Trinity Biotech Announces Q3 2024 Financial Results

Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV…

Why Is Clinical Diagnostics Focused Trinity Biotech Stock Trading Higher On Tuesday?

Tuesday, Trinity Biotech plc (NASDAQ:TRIB) stock is trading higher with a session volume of 14.32 million versus the average volume…

Trinity Biotech Announces Q2 2024 Financial Results

-Q2, 2024 total revenues of $15.8 million grew +14% Y/Y and +7.7% Q/Q based on strong demand and output in…

Global Urinalysis Market Size To Exceed USD 6.76 Billion By 2033 | CAGR of 5.41%

The Global Urinalysis Market Size was Valued at USD 3.99 Billion in 2023 and the Worldwide Urinalysis Market Size is…

Trinity Biotech: Das sind die jüngsten Quartalszahlen

Trinity Biotech hat am 23.05.2024 die Bücher zum am 31.03.2024 abgelaufenen Quartal geöffnet.Trinity Biotech hat im jüngsten Jahresviertel einen Verlust…

Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance

-Business performance on track to achieve approximately $20 million of annualized run-rate EBITDASO1 on annualized revenues of approximately $75 million…

Trinity Biotech veröffentlichte Zahlen zum vergangenen Quartal

Trinity Biotech veröffentlichte am 04.04.2024 auf der all-dreimonatlichen Finanzkonferenz die Zahlen zum am 31.12.2023 abgelaufenen Jahresviertel.Das EPS wurde auf einen…

Ausblick: Trinity Biotech legt Zahlen zum jüngsten Quartal vor

Trinity Biotech präsentiert am 04.04.2024 die Bilanzzahlen zum am 31.12.2023 beendeten Jahresviertel.Die Schätzung von 1 Analyst geht beim Ergebnis je…

Trinity Biotech regains Nasdaq compliance with share price By Investing.com

Trinity Biotech regains Nasdaq compliance with share price…

dpa-AFX ProFeed